Liraglutide Research
Explore peptide research and guides on liraglutide research.
Liraglutide Research
Is Saxenda Still Worth It in 2026?
Liraglutide (Saxenda) produces 8% weight loss vs 15-21% for semaglutide and tirzepatide. Cost, safety data, and niche uses still give it a role in 2026.
Liraglutide ResearchLiraglutide (Saxenda) for Weight Loss
Liraglutide produces 8% weight loss in clinical trials but falls behind semaglutide (15.8%) and tirzepatide (20.2%). Where Saxenda fits in the GLP-1 era.